Specifically, the BET inhibitor OTX015 has shown great efficacy in binding to and competitively inhibiting BRD2, BRD3, and BRD4, leading to neuroblastoma cell death in‐vitro and decreased tumor volume in vivo.15, 16. Here, DNER is linked to neuroblastoma.